306 related articles for article (PubMed ID: 29363651)
1. Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning.
Liu SM; Zhao WL; Song HQ; Meng R; Li SJ; Ren CH; Ovbiagele B; Ji XM; Feng WW
Chin Med J (Engl); 2018 Feb; 131(3):347-351. PubMed ID: 29363651
[TBL] [Abstract][Full Text] [Related]
2. Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study.
Liu S; Gao Z; Meng R; Song H; Tang T; Zhao Y; Chen R; Sheng Y; Fan Q; Jiang F; Zhang Q; Ding J; Huang X; Ma Q; Dong K; Xue S; Yu Z; Duan J; Chu C; Chen X; Huang X; Li S; Ovbiagele B; Zhao W; Ji X; Feng W
Front Neurol; 2021; 12():748916. PubMed ID: 34975717
[No Abstract] [Full Text] [Related]
3. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
4. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
[TBL] [Abstract][Full Text] [Related]
5. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.
Johnston SC; Easton JD; Farrant M; Barsan W; Battenhouse H; Conwit R; Dillon C; Elm J; Lindblad A; Morgenstern L; Poisson SN; Palesch Y
Int J Stroke; 2013 Aug; 8(6):479-83. PubMed ID: 23879752
[TBL] [Abstract][Full Text] [Related]
6. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
8. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
9. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.
Liu L; Wong KS; Leng X; Pu Y; Wang Y; Jing J; Zou X; Pan Y; Wang A; Meng X; Wang C; Zhao X; Soo Y; Johnston SC; Wang Y;
Neurology; 2015 Sep; 85(13):1154-62. PubMed ID: 26330567
[TBL] [Abstract][Full Text] [Related]
12. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP;
J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789
[TBL] [Abstract][Full Text] [Related]
13. The Acute S
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Rivaroxaban versus Aspirin for Non-disabling Cerebrovascular Events (TRACE): study protocol for a randomized controlled trial.
Yang F; Jiang W; Bai Y; Han J; Liu X; Zhang G; Zhao G
BMC Neurol; 2015 Oct; 15():195. PubMed ID: 26458895
[TBL] [Abstract][Full Text] [Related]
15. High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial.
Li J; Zhao X; Meng X; Lin J; Liu L; Wang C; Wang A; Wang Y; Wang Y;
Stroke; 2016 Aug; 47(8):2025-30. PubMed ID: 27328699
[TBL] [Abstract][Full Text] [Related]
16. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
[TBL] [Abstract][Full Text] [Related]
17. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
[TBL] [Abstract][Full Text] [Related]
18. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
